switching from semaglutide to tirzepatide dose How can I transition a patient a weekly 0.5 mg of an equivalent dose? Transitioning Treatments: What to Expect

It is not known if RYBELSUS will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use RYBELSUS if: you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in RYBELSUS Before using RYBELSUS, tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys have a history of vision problems related to your diabetes are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or plan to become pregnant

They were particularly interested in its suggested ability to hasten gastric emptying

Some continue longer based on clinical judgment

Studies suggest this dual approach produces a 3-5 fold increase in growth hormone release compared to either peptide alone, while maintaining natural pulsatile secretion patterns

For todays newsletter, I am re-releasing a podcast about the story behind the most important class of drugs thats ever been developed